Site navigation

Navigation

Renal transplantation - immuno-suppressive regimens (adults)

The clinical effectiveness and cost effectiveness of immuno-suppressive therapy for renal transplantation

Summary

NICE has made the following recommendations about the use of immunosuppressive drugs in adults receiving kidney transplants: Doctors should consider using basiliximab or daclizumab for induction treatment (immediately after the kidney transplant). These drugs should be used with a combination of o ...

Read the complete summary


Guidance documents

Implementing this guidance

  • None available

Other information

About this guidance

Technology appraisals TA85

Issued: September 2004

How this guidance was produced

See also:

See this guidance in practice:

Order printed copies of this guidance